The effects of antidepressants in parkinson's disease: A meta-analysis

被引：20
|
作者：
Frisina, Pasquale G. [1 ,2 ]
Tenenbaum, Harriet R. [3 ]
Borod, Joan C. [4 ,5 ]
机构：
[1] Jewish Home & Hosp, Dept Med Res, Leir Parkinsons Dis Program, Lifecar Syst, New York, NY 10025 USA
[2] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA
[3] Kingston Univ, Dept Psychol, Kingston upon Thames KT1 2EE, Surrey, England
[4] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA
[5] Grad Ctr City Univ New York, Flushing, NY 11367 USA
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2008年 / 118卷 / 05期
关键词：
depression; meta-analysis; Parkinson's disease; treatment;
D O I：
10.1080/00207450701239418
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
This study explored the therapeutic effect of antidepressants in Parkinson's disease (PD) using a meta-analysis. Altogether, 24 placebo-controlled trials qualified for inclusion and revealed that tricyclic antidepressants (TCAs) had a greater antidepressant effect relative to selective serotonin reuptake inhibitors (SSRIs), Qb(1) = 8.87, p < .01, and the mono-amine-oxidase inhibitor, selegiline, Qb(1) = 7.90, p < .01. Whereas TCAs produced a significant side effect profile (odds ratio = 3.07), adverse events were negligible with SSRIs (odds ratio = 1.83) and selegeline (odds ratio = 1.63). Antidepressants can be beneficial for patients with PD. However, the choice of antidepressants needs to take depressive symptomatologies into account while monitoring side effects.
引用
收藏
页码：667 / 682
页数：16
相关论文
共 50 条
  • [21] Prediabetes and the incidence of Parkinson's disease: A meta-analysis
    Jin, Xiaojie
    Lu, Yi
    Gong, Zhongying
    Huang, Weihui
    Wang, Zhiyun
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 722 - 730
  • [22] Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis
    Terracciano, Antonio
    Aschwanden, Damaris
    Stephan, Yannick
    Cerasa, Antonio
    Passamonti, Luca
    Toschi, Nicola
    Sutin, Angelina R.
    MOVEMENT DISORDERS, 2021, 36 (08) : 1863 - 1870
  • [23] Parkinson's Disease and Convergence Insufficiency: A Meta-Analysis
    Al-Namaeh, Mashael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [24] Familial aggregation of Parkinson's disease: A meta-analysis
    Thacker, Evan L.
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2008, 23 (08) : 1174 - 1183
  • [25] A meta-analysis of Parkinson's disease and exposure to pesticides
    Priyadarshi, A
    Khuder, SA
    Schaub, EA
    Shrivastava, S
    NEUROTOXICOLOGY, 2000, 21 (04) : 435 - 440
  • [26] The effect of istradefylline for Parkinson's disease: A meta-analysis
    Sako, Wataru
    Murakami, Nagahisa
    Motohama, Keisuke
    Izumi, Yuishin
    Kaji, Ryuji
    SCIENTIFIC REPORTS, 2017, 7
  • [27] Telomere length in Parkinson's disease: A meta-analysis
    Forero, Diego A.
    Gonzalez-Giraldo, Yeimy
    Lopez-Quintero, Catalina
    Castro-Vega, Luis J.
    Barreto, George E.
    Perry, George
    EXPERIMENTAL GERONTOLOGY, 2016, 75 : 53 - 55
  • [28] Theory of mind in Parkinson's disease: A meta-analysis
    Bora, Emre
    Walterfang, Mark
    Velakoulis, Dennis
    BEHAVIOURAL BRAIN RESEARCH, 2015, 292 : 515 - 520
  • [29] Creatine for patients with Parkinson's disease: A meta-analysis
    Attia, A.
    Ahmed, H.
    Morsi, M.
    Awad, K.
    Elnenny, M.
    Ghanem, E.
    Negida, A.
    MOVEMENT DISORDERS, 2016, 31 : S635 - S636
  • [30] The effect of istradefylline for Parkinson’s disease: A meta-analysis
    Wataru Sako
    Nagahisa Murakami
    Keisuke Motohama
    Yuishin Izumi
    Ryuji Kaji
    Scientific Reports, 7
12345